PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

• L. I. Pinczes,
• F. Magyari,
• E. Páyer,
• K. Farkas,
• S. Ujfalusi,
• Á. Diószegi,
• A. Deme,
• M. Sik,
• G. Nagy,
• Z. Hevessy,
• B. Nagy, Jr.,
• Á. Illés

Affiliations

L. I. Pinczes

1 Division of Hematology, Department of Internal Medicine

F. Magyari

1 Division of Hematology, Department of Internal Medicine

E. Páyer

1 Division of Hematology, Department of Internal Medicine

K. Farkas

1 Division of Hematology, Department of Internal Medicine

S. Ujfalusi

2 Division of Endocrinology, Department of Internal Medicine

Á. Diószegi

2 Division of Endocrinology, Department of Internal Medicine

A. Deme

3 Department of Internal Medicine

M. Sik

4 Department of Radiology

G. Nagy

5 Department of Emergency Medicine

Z. Hevessy

6 Department of Laboratory Medicine, University of Debrecen, Debrecen, Hungary

B. Nagy, Jr.

6 Department of Laboratory Medicine, University of Debrecen, Debrecen, Hungary

Á. Illés

1 Division of Hematology, Department of Internal Medicine